BET inhibitors targeting BET proteins have also been investigated; the BET inhibitors JQ1 and I‐BET151 are known to suppress the growth of NSCLC [14], with JQ1 also having an effect on Kras‐mutant NSCLC [15]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.